Eosinophils and the skin;EOSINOPHLES ET PEAU: ACTUALITES

Annales de Dermatologie et de Venereologie

Volumn 123, Issue 8, 1996, Pages 498-509

  Dubost Brama, A ^a   Dubucquoi, S ^b   Janin, A ^a   Capron, M ^c   Delaporte, E ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EOSINOPHILIA; HUMAN; EOSINOPHIL; PATHOLOGY; PHYSIOLOGY; REVIEW; SKIN DISEASE; ULTRASTRUCTURE;

EOSINOPHILIA; EOSINOPHILS; HUMANS; SKIN DISEASES;

EID: 0030341104     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. De Graciansky P, Leclercq R. Les éosinophilies en dermatologie. Rev Prat 1957;20:2203-13.
2. Butterworth AE, David JR. Eosinophil function. N Engl J Med 1981;15:154-6.
3. Leiferman KM. A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol 1991;24: 1101-12.
4. Dubucquoi S, Capron M. L'éosinophile : une cellule à deux visages dans la réponse inflammatoire. In : Inflammation, Médecine/Sciences. John Libbey Eurotext (Ed) (sous presse).
5. Capron M, Desreumaux P, Soussi Gouni A, Lamkhioued B, Capron A. L'éosinophile, bénéfique ou néfaste : une cellule à part entière dans la réponse immunitaire. C R Soc Biol 1994;188:39-46.
6. Capron M, Truong M-J, Desreumaux P, Lamkhioued B, Tomassini M, Capron A. Eosinophil membrane receptors: function of IgE-and IgA-binding molecules. In : Gleich GJ, Kay AB, ed. Eosinophils in allergy and inflammation. Marcel Dekker Inc, 1994:225-37.
7. Abu-Ghazaleh RI, Kita H, Gleich GJ. Eosinophil activation and function in health and disease. Immunol Ser 1992;57:137-167.
8. Weller PF. Eosinophils: structure and function. Curr Op Immunol 1994;6:85-90.
9. Schleimer RP, Bochner BS. The effects of glucocorticoids on human eosinophils. J. Allergy Clin Immunol 1994;94:1202-13.
10. Stahle-Bäckdahl M, Inoue M, Giudice GJ, Parks WC. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 1994;93:2022-30.
11. Delaporte E, Bieber T, Viac J, Faure M, Nicolas J-F. Cytokines épidermiques et inflammation cutanée. Ann Derm Venereol 1994;121:836-43.
12. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994;94:1183-8.
13. Lamkhioued B, Aldebert D, Soussi Gounni A, Delaporte E, Goldman M, Capron A et al. Synthesis of cytokines by eosinophils and their regulation. Int Arch Allergy Immunol 1995; 107:122-3.
14. Fantini F, Magnoni C, Pincelli C, Gianetti A. Neurogenic inflammation and the skin: neural modulation of cutaneous inflammatory reactions. Eur J Dermatol 1995;5:349-57.
15. Capron M, Plumas J. Eosinophil membrane receptors. In: Makino S, Fukuda T, ed. Eosinophils: biological and clinical aspects. CRC press 1993:95-123.
16. Soussi-Gouni A, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A et al. Expression of the high affinity immunoglobulin E receptor on eosinophils: involvement in immune defence against parasites. Nature 1994;367:183-6.
17. Aldebert D, Lamkhioued B, Desaint C, Soussi Gounni A, Goldman M, Capron A et al. Eosinophil express a functional receptor for IFN alpha: inhibitory role of interferon alpha on the release of mediators. Blood 1996:87:2354-60.
18. Czech W, Krutmann J, Budnik A, Schöpf E, Kapp A. Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J Invest Dermatol 1993;100:417-23.
19. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein la induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-95.
20. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
21. Laberge S, Cruikshank WW, Beer DJ, Center DM. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 1996;156:310-315.
22. Schröder JM, Noso N, Sticherling M, Christophers E. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J Leukoc Biol 1996;59:1-5.
23. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-7.
24. Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1β-induced transendothelial migration. J Immunol 1992;149:4021-8.
25. Walsh G, Hartnell A, Wardlaw A, Kurihara K, Sanderson J, Key A. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrine (CD11/CD18) dependent manner. Immunology 1990;71:258-65.
26. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-6.
27. Kapp A, Zeck-Kapp G, Czech W, Schöpf E. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J Invest Dermatol 1994;102:906-14.
28. Tomassini M, Tsicopoulos A, Tai PC, Gruart V, Tonnel AB, Prin L, Capron A, Capron M. Release of granule proteins by eosinophil from allergic and non allergic patients with eosinophilia on immunoglobulin-dependent activation. J. Allergy Clin Immunol 1991;88:365-75.
29. Prin L, Capron M, Tonnel AB, Bletry O, Capron A. Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol 1983; 72:336-46.
30. Czarnetzki BM. Les polynucléaires éosinophiles. Ann Derm Venereol 1987;114:1147-56.
31. Litoux P, Stalder JF, Dreno B. Dermatoses éosinophiliques. In: Saurat JH, Grosshans E, Laugier P, Lachapelle JM eds, Dermatologie et Vénéréologie, 2nd ed. Masson, Paris 1991:505-13.
32. Leiferman KM. Eosinophil in atopic dermatitis. Allergy, 1989:44(suppl 9):20-6.
33. Haas N, Motel K, Czarnetzki B. Comparative immunoreactivity of the eosinophil constituents MBP and ECP in different types of urticaria. Arch Dermatol Res 1995;287:180-5.
34. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990;15:264-66.
35. Bruijnzeel PLB, Kuijper PHM, Rihs S, Betz S, Warringa RAJ, Koenderman L. Eosinophil migration in atopic dermatitis I: increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J Invest Dermatol 1993;100:137-42.
36. Leung DYM. Role of IgE in atopic dermatitis. Curr Op Immunol 1993;5:956-62.
37. Tanaka Y, Delaporte E, Dubucquoi S, Soussi Gounni A, Porchet E, Capron A et al. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol 1994;103:589-92.
38. Tanaka Y, Takenaka M, Matsunaga Y, Okada S, Anan S, Yoshida H et al. High affinity IgE receptor (FcεRI) expression on eosinophils infiltrating the lesions and mite patch tested sites in atopic dermatitis. Arch Dermatol Res 1995;287:712-7.
39. Bruynzeel-Koomen CAFM, Van Wichen DF, Spry CJF, Venge P, Bruynzeel PLB. Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol 1988;118:229-38.
40. Kapp A, Czech W, Krutmann J, Schöpf E. Eosinophil cationic protein in sera of patients with atopic dermatitis. J Am Acad Dermatol 1991;24:555-8.
41. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis-eosinophil granule proteins as markers of disease activity. Allergy 1993;48:1-5.
42. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-37.
43. Wahlgren C-F, Tengvall Linder M, Scheynius A. Effects of cyclosporin A in atopic dermatitis: expression in the skin of IgE, low-affinity Fc-IgE receptors, ICAM-1 and eosinophilic granulocytes. Eur J Dermatol 1992;2:112-8.
44. Leiferman KM, Fujisawa T, Gray BH, Gleich GJ. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 1990;62:579-89.
45. Peters MS, Schroeter AL, Kephart GM, Gleich GJ. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol 1983;81:39-43.
46. Mcevoy MT, Peterson EA, Kobza-Black A, English JSC, Dover JS, Murphy GM et al. Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol 1995;133:853-60.
47. Leiferman KM, Norris PG, Murphy GM, Hawk JLM, Winkelmann RK. Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria. J Am Acad Dermatol 1989;27:75-80.
48. Leiferman KM, Peters MS, Gleich GJ. The eosinophil and cutaneous edema. J Am Acad Dermatol 1986;75:513-7.
49. Songsiridej V, Peters MS, Dor PJ, Ackerman SJ, Gleich GJ, Busse WW. Facial edema and eosinophilia. Evidence for eosinophil degranulation. Ann Intern Med 1985;103:503-6.
50. Finkelman FD, Pearce EJ, Urban JF Jr, Sher A. Regulation and biological function of helminth-induced cytokine responses. Immunol Today 1991;12:62-6.
51. Goldstein SM, Wassermann SI, Wintroub BU. Mast cell and eosinophil mediated damage in bullous pemphigoid. Immunol Ser 1989;46:527-45.
52. Asbrink E, Hovmark A. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies. Acta Derm Venereol 1984;64:243-73.
53. Dubertret L, Bertaux B, Fosse M, Touraine R. Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol 1980;104:615-24.
54. Scheman AJ, Hordinsky MD, Groth DW, Vercellotti GM, Leiferman KM. Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis. Arch Dermatol 1989;125: 1079-83.
55. Thyresson NH, Goldberg NC, Tye MJ, Leiferman KM. Localization of eosinophil granule major basic protein in incontinentia pigmenti. Pediatric Dermatol 1991;8:102-6.
56. Selvaag E, Roald B, Larsen TE, Thune P. Eosinophil cationic protein in perilesional skin of incontinentia pigmenti Bloch-Sulzberger. Eur J Pediat Dermatol 1994;4:9-12.
57. Ward JC, Gitlin JB, Garry DJ, Jatoi A, Luikart SD, Zelickson BD, Dahl MV, Skubitz KM. Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxiciiy. Br J Haematol 1992;81:27-32.
58. Daoud MS, Su WPD, Leiferman KM, Perniciaro C. Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 1994;30:937-43.
59. Tsuda S, Miyasato M, Iryo K, Nakama T, Kato K, Sasai Y. Eosinophil phenotypes in bullous pemphigoid. J Dermatol 1992; 19:270-79.
60. Cox NH, Cooper N, Venge P, Friedmann PS. Eosinophil cationic protein in bullous pemphigoid, dermatitis herpetiformis and other blistering disorders. Eur J Dermatol 1993;3:294-8.
61. Czech W, Schaller J, Schöpf E, Kapp A. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J Am Acad Dermatol 1993; 29:210-5.
62. Iryo K, Tsuda S, Sasai Y. Ultrastructural aspects of infiltrated eosinophils in bullous pemphigoid. J Dermatol 1992;19: 393-9.
63. Endo H, Iwamoto I, Fujita M, Okamoto S, Yoshida S. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid. Arch Dermatol Res 1992;284:312-4.
64. Desreumaux P, Janin A, Delaporte E, Dubucquoi S, Piette F, Cortot A et al. Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis. Gut 1995;37:132-5.
65. Delaporte E, Dubost-Brama A, Ghohestani R, Nicolas JF, Neyrinck JL, Bergoend H et al. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol. A paraître.
66. Mezei MM, Tron VA, Stewart WD, Rivers JK, Eosinophilic ulcer of the oral mucosa. J Am Acad Dermatol 1995;33:734-40.
67. Dereure O, Meyer F, Ciurana AJ, Guilhou JJ. Dermatological manifestations of idiopathic hypereosinophilic syndrome: a unusual observation with protacted course and literature review. Eur J Dermatol 1994;4:110-6.
68. Ofuji S, Ogino A, Horio T, Ohseko T, Uehara M. Eosinophilic pustular folliculitis. Acta Dermatol Venereol 1970;50: 195-203.
69. Carsuzaa F, Pierre C, Branquart H. Maladie d'Ofuji et pustuloses folliculaires à éosinophiles. Ann Dermatol Venereol 1992;119:780-5.
70. Aoyarna H, Tagami H. Eosinophilic pustular folliculitis starting initially only with palmoplantar pustular lesions. Report of a case and review of the literature. Dermatology 1992;185:276-80.
71. Rosenthal D, LeBoit PE, Klumpp L, Berger TG. Human immunodeficiency virus associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 1991;127:206-9.
72. Taïeb A, Bassan-Andrieu L, Maleville J. Eosinophilic pustulosis of the scalp in childhood. J Am Acad Dermatol 1992;27:55-60.
73. McCalmont TH, Altemus D, Maurer T, Berger TG. Eosinophilic folliculitis. The histologic spectrum. Am J Dermatopathol 1995;17:439-46.
74. Andreano JM, Kantor GR, Bergfeld WF, Tuthill RJ, Taylor JS. Eosinophilic cellulitis and eosinophilic pustular folliculitis. J Am Acad Dermatol 1989;20:934-6.
75. Magro CMJ, Crowson AN. Eosinophilic pustular follicular reaction: a paradigm of immune dysregulation. Int J Dermatol 1994;33:172-8.
76. Teraki Y, Imanishi K, Shiohara T. Ofuji's disease and cytokines: remission of eosinophilic pustular folliculitis associated with increased serum concentrations of interferon gamma. Dermatology 1996;192:16-18.
77. Mohr C, Schütte B, Hildebrand A, Luger TA, Kolde G. Eosinophilic pustular folliculitis: successful treatment with interferonalpha. Dermatology 1995;191:257-9.
78. Teraki Y, Konohana I, Shiohara T, Nagashima M, Nishikawa T. Eosinophilic pustular folliculitis (Ofuji's disease) Immunohistochemical analysis. Arch Dermatol 1993;129:1015-9.
79. Leal-Khouri S, Mallory SB, Santa Cruz DJ, Hookerman BJ. Wells' syndrome: a case report and review of the literature. Eur J Dermatol 1993;3:105-7.
80. Bonvalet D, Caron C, Level R, Mousset S, Civatte J. Le syndrome de Wells ou cellulite à éosinophiles. A propos de deux cas. Revue de la littérature. Ann Derm Venereol. 1983;110:899-907.
81. Anderson CR, Jenkins D, Tron V, Prendiville JS. Wells' syndrome in childhood: case report and review of the literature. J Am Acad Dermatol 1995;33:857-64.
82. Winkelmann RK, Frigas E. Eosinophilic panniculitis: a clinicopathologic study. J Cutan Pathol 1986;13:1-12.
83. Samlaska CP, De Lorimier AJ, Heldman LS. Eosinophilic panniculitis. Pediatr Dermatol 1995;12:35-8.
84. Adame J, Cohen PR. Eosinophilic panniculitis: diagnostic considerations and evaluation. J Am Acad Dermatol 1996;34: 229-34.
85. Brehmer-Andersson E, Kaaman T, Skog E, Frithz A. The histopathogenesis of the flame figure in Wells' syndrome based on five cases. Acta Derm Venereol 1986;66:213-9.
86. Ferrier MC, Janin-Mercier A, Souteyrand P, Bourges M, Hermier C. Eosinophilic cellulitis (Wells'syndrome): ultrastructural study of a case with circulating immune complexes. Dermatologica 1988;176:299-304.
87. Peters MS, Schroeter AL, Gleich GJ. Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol 1983;109:141-8.
88. Tsuda S, Tanaka K, Miyasato M, Nakama T, Sasai Y. Eosinophilic cellulitis (Well's syndrome) associated with ascariasis. Acta Derm Venereol 1994;74:292-4.
89. Aberer W, Konrad K, Wolff K. Well's syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol 1988;18:105-14.
90. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med 1984;310:1621-6.
91. Katzen DR, Leiferman KM, Weller PF, Leung DYM. Hypereosinophilia and recurrent angioneurotic edema in a 2 1/2-year-old girl. Am J Dis Child 1986;140:62-4.
92. Putterman C, Barak V, Caraco Y, Neuman T, Shalit M. Episodic angioedema with eosinophilia: a case associated with T cell activation and cytokine production. Ann Allergy 1993;70:243-8.
93. Mathieu A, Calvo F, Pruna A, Dallot A, Morel P. Angioœdème cyclique avec éosinophilie. Ann Derm Venereol 1986; 113:1002-5.
94. Wolf C, Pehamberger H, Breyer S, Leiferman KM, Wolff K. Episodic angioedema with eosinophilia. J Am Acad Dermatol 1989;20;21-7.
95. Lassalle P, Gosset P, Gruart V, Prin L, Capron M, Lagrue G et al. Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia. Clin Exp Immunol 1990;82:38-43.
96. Butterfield JH, Leiferman KM, Abrams J, Silver JE, Bower J, Gonchoroff N. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 1992; 79:688-92.
97. Chen KR, Pittelkow MR, Su WPD, Gleich GJ, Newman W, Leiferman KM. Recurrent cutaneous necroziting eosinophilic vasculitis. A novel eosinophil-mediated syndrome. Arch Dermatol 1994; 130:1159-66.
98. Butterfield JH, Leiferman KM, Gleich GJ. Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy 1993;23:571-80.
99. Zenarola P, Melillo L, Bisceglia M, Carotenuto M, Lomuto M. NERDS syndrome: an additional case report. Dermatology 1995; 191:133-138.
100. Rebora A. Do we really need NERDS? Dermatology 1995; 191:81.
101. Thivolet J, Pierini AM, Hermier C, Souteyrand P. Nodulomatose éosinophilique transitoire. Ann Dermatol Venereol 1980;107:879-86.
102. Combemale P, Chouvet B, Dupin M, Guennoc B. Nodulose éosinophilique transitoire, Ann Dermatol Venereol 1995;122(suppl I):S13.
103. Hauser C, Saurat JH. A syndrome characterized by nodular eosinophilic infiltration of the skin and immunoglobulin isotype imbalance. J Am Acad Dermatol 1991;24;352-5.